1971-1980 of 2672 results
Milk products, hashtags and the metaverse: the latest trade mark updates
Over the past few months, the Federal Court and Federal Circuit and Family Court have handed down some important and interesting trade mark decisions concluding: ...
Seeking cover under pressure
Over the past decade, there has been a significant increase in the pace and scale of regulatory investigations and enforcement activity, including a spate of high profile royal commissions and inquiries into potential wrongdoing by institutions, companies, and their directors and officers. ...
Allens advises Sunsuper on merger with QSuper
The landmark merger of Sunsuper and QSuper will form the country's second-biggest superannuation fund. The merged entity, Australian Retirement Trust, will have over 2 million members and more than ...
Reminder – AUSTRAC compliance reports are due
With 2022 now in full swing and the due date for AUSTRAC compliance reports just around the corner (on 31 March 2022), we take a look at some recent changes to the form and how they will affect reporting entities. ...
Allens advises Sydney councils on landmark renewables offtake
Beginning this year and running until 2026 with an option to extend to 2030, the agreement is one of the largest Australian municipal renewables offtakes. FRV's 56 MW Moree solar farm, AMP's 120 MW ...
New year, new regulations: what to know about EP&A Regulation
The Environmental Planning and Assessment Regulation 2021 (2021 Regulation) comes into effect on 1 March 2022. Here, we explain the key things you need to know to prepare yourself for these changes. ...
Big batteries – charging up for 2022
With ARENA's recently announced Large Scale Battery Storage Funding Round and the implementation of targeted regulatory reform on the horizon, investment in big batteries is expected to boom. In this Insight, we look at recent policy and regulatory developments, and highlight some of the key trends we are seeing in the big batteries space. ...
Interlocutory injunction refused based on 'doubtful' patent term extension
In the fight against patent infringement, challenging the validity of patent term extensions (PTEs) is increasingly becoming the weapon of choice for generic pharmaceutical companies. Since around the mid-2000s, patentees in pharmaceutical patent cases have typically been successful in bids for interlocutory injunctions, aiming to prevent the launch of generic products in Australia. The recent Biogen decision by the Federal Court is the latest in a trend of refusing interlocutory injunctions, and a clear indication the tide is turning. ...
Allens recognised as top graduate employer
The firm was ranked: Top law graduate employer for the third year in a row (2022 AAGE Top Graduate Employers) Top law graduate employer (GradAustralia's Top 100 Graduate Employers) Most Popular ...
Rezoning reforms: rewriting the rulebook
The release of the new LEP guideline in December 2021 was the first step towards major rezoning reform. Â The second step - outlined in a discussion paper by the Department of Planning and Environment (DPE) aims to rewrite the rulebook. Here, we explore the changes already made, as well as those open for comment. ...